Abcellera Biologics Stock Price History

ABCL Stock  USD 3.00  0.17  6.01%   
If you're considering investing in Abcellera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Abcellera Biologics stands at 3.00, as last reported on the 29th of November, with the highest price reaching 3.07 and the lowest price hitting 2.87 during the day. Abcellera Biologics appears to be slightly risky, given 3 months investment horizon. Abcellera Biologics secures Sharpe Ratio (or Efficiency) of 0.0924, which signifies that the company had a 0.0924% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Abcellera Biologics, which you can use to evaluate the volatility of the firm. Please makes use of Abcellera Biologics' mean deviation of 2.87, and Risk Adjusted Performance of 0.064 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Abcellera Biologics' Common Stock Shares Outstanding is quite stable compared to the past year. Other Stockholder Equity is expected to rise to about 127.1 M this year, although the value of Common Stock Total Equity will most likely fall to about 479 M. . The value of Price To Sales Ratio is estimated to slide to 41.25. Price Earnings Ratio is expected to rise to -10.71 this year. Abcellera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0924

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsABCL
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.93
  actual daily
34
66% of assets are more volatile

Expected Return

 0.36
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Abcellera Biologics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abcellera Biologics by adding it to a well-diversified portfolio.
Price Book
0.8219
Enterprise Value Ebitda
5.3008
Price Sales
26.8824
Shares Float
189 M
Wall Street Target Price
12.2857

Abcellera Biologics Stock Price History Chart

There are several ways to analyze Abcellera Stock price data. The simplest method is using a basic Abcellera candlestick price chart, which shows Abcellera Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 11, 20243.15
Lowest PriceSeptember 6, 20242.39

Abcellera Biologics November 29, 2024 Stock Price Synopsis

Various analyses of Abcellera Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Abcellera Stock. It can be used to describe the percentage change in the price of Abcellera Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Abcellera Stock.
Abcellera Biologics Price Action Indicator 0.12 
Abcellera Biologics Price Rate Of Daily Change 1.06 
Abcellera Biologics Price Daily Balance Of Power 0.85 

Abcellera Biologics November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Abcellera Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Abcellera Biologics intraday prices and daily technical indicators to check the level of noise trading in Abcellera Stock and then apply it to test your longer-term investment strategies against Abcellera.

Abcellera Stock Price History Data

The price series of Abcellera Biologics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 0.76 with a coefficient of variation of 5.81. The prices are distributed with arithmetic mean of 2.67. The median price for the last 90 days is 2.68.
OpenHighLowCloseVolume
11/29/2024
 2.88  3.07  2.87  3.00 
11/27/2024 2.88  3.07  2.87  3.00  4,282,500 
11/26/2024 2.90  2.94  2.80  2.83  1,754,078 
11/25/2024 2.80  3.02  2.80  2.95  2,518,320 
11/22/2024 2.74  2.83  2.71  2.76  1,806,910 
11/21/2024 2.66  2.77  2.61  2.72  1,427,916 
11/20/2024 2.69  2.72  2.62  2.67  1,718,744 
11/19/2024 2.63  2.72  2.61  2.71  1,818,649 
11/18/2024 2.66  2.71  2.59  2.65  2,501,826 
11/15/2024 2.75  2.76  2.57  2.65  3,269,241 
11/14/2024 2.96  2.97  2.76  2.76  2,755,600 
11/13/2024 3.00  3.09  2.90  2.92  2,664,425 
11/12/2024 3.09  3.09  2.93  2.96  3,998,328 
11/11/2024 2.72  3.18  2.72  3.15  7,641,436 
11/08/2024 2.71  2.75  2.62  2.70  2,166,318 
11/07/2024 2.80  2.84  2.63  2.72  2,347,285 
11/06/2024 2.74  2.81  2.64  2.76  1,683,189 
11/05/2024 2.50  2.79  2.50  2.72  3,835,950 
11/04/2024 2.76  2.90  2.72  2.89  3,644,134 
11/01/2024 2.74  2.80  2.72  2.73  1,244,488 
10/31/2024 2.76  2.78  2.70  2.73  955,107 
10/30/2024 2.83  2.89  2.78  2.78  1,230,039 
10/29/2024 2.86  2.89  2.77  2.83  1,154,037 
10/28/2024 2.75  2.91  2.74  2.89  2,850,235 
10/25/2024 2.70  2.86  2.70  2.72  2,300,887 
10/24/2024 2.80  2.84  2.64  2.70  3,254,587 
10/23/2024 2.81  2.83  2.73  2.78  1,113,443 
10/22/2024 2.78  2.84  2.74  2.84  1,212,626 
10/21/2024 2.90  2.92  2.71  2.77  2,065,635 
10/18/2024 2.69  2.89  2.69  2.87  3,155,545 
10/17/2024 2.62  2.69  2.59  2.68  2,330,764 
10/16/2024 2.56  2.62  2.54  2.62  1,159,103 
10/15/2024 2.53  2.61  2.51  2.56  1,826,001 
10/14/2024 2.60  2.60  2.43  2.52  2,040,126 
10/11/2024 2.50  2.62  2.50  2.59  1,732,198 
10/10/2024 2.49  2.53  2.41  2.50  1,650,551 
10/09/2024 2.56  2.61  2.47  2.49  1,110,912 
10/08/2024 2.61  2.62  2.53  2.57  1,303,846 
10/07/2024 2.49  2.64  2.49  2.63  1,671,598 
10/04/2024 2.51  2.55  2.44  2.50  1,078,727 
10/03/2024 2.48  2.50  2.44  2.48  1,235,209 
10/02/2024 2.55  2.58  2.45  2.48  1,631,201 
10/01/2024 2.58  2.63  2.53  2.57  2,287,553 
09/30/2024 2.59  2.70  2.58  2.60  1,381,668 
09/27/2024 2.60  2.64  2.56  2.61  1,559,676 
09/26/2024 2.46  2.56  2.46  2.56  1,240,443 
09/25/2024 2.51  2.54  2.43  2.44  1,445,345 
09/24/2024 2.48  2.56  2.46  2.52  1,680,259 
09/23/2024 2.62  2.63  2.48  2.48  1,581,504 
09/20/2024 2.73  2.73  2.50  2.59  3,247,703 
09/19/2024 2.81  2.86  2.73  2.74  1,473,644 
09/18/2024 2.72  2.93  2.71  2.75  1,886,845 
09/17/2024 2.68  2.87  2.66  2.73  2,191,763 
09/16/2024 2.75  2.77  2.59  2.68  2,441,053 
09/13/2024 2.73  2.79  2.64  2.75  2,406,099 
09/12/2024 2.72  2.74  2.60  2.68  1,410,299 
09/11/2024 2.56  2.73  2.50  2.69  3,095,577 
09/10/2024 2.40  2.60  2.34  2.58  3,264,949 
09/09/2024 2.41  2.53  2.37  2.40  2,215,788 
09/06/2024 2.44  2.47  2.36  2.39  1,832,608 
09/05/2024 2.52  2.57  2.42  2.43  2,404,556 

About Abcellera Biologics Stock history

Abcellera Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abcellera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abcellera Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abcellera Biologics stock prices may prove useful in developing a viable investing in Abcellera Biologics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding289.2 M290.3 M
Net Income Applicable To Common Shares182.3 M94.4 M

Abcellera Biologics Quarterly Net Working Capital

701.17 Million

Abcellera Biologics Stock Technical Analysis

Abcellera Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Abcellera Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Abcellera Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Abcellera Biologics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Abcellera Biologics' price direction in advance. Along with the technical and fundamental analysis of Abcellera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abcellera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Abcellera Biologics is a strong investment it is important to analyze Abcellera Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera Biologics' future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.459
Earnings Share
(0.61)
Revenue Per Share
0.112
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.13)
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.